117 related articles for article (PubMed ID: 16884687)
1. BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells.
Ozawa S; Kato Y; Komori R; Maehata Y; Kubota E; Hata R
Biochem Biophys Res Commun; 2006 Sep; 348(2):406-12. PubMed ID: 16884687
[TBL] [Abstract][Full Text] [Related]
2. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
[TBL] [Abstract][Full Text] [Related]
3. A New Strategy to Find Targets for Anticancer Therapy: Chemokine CXCL14/BRAK Is a Multifunctional Tumor Suppressor for Head and Neck Squamous Cell Carcinoma.
Hata R
ISRN Otolaryngol; 2012; 2012():797619. PubMed ID: 23762619
[TBL] [Abstract][Full Text] [Related]
4. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells.
Shellenberger TD; Wang M; Gujrati M; Jayakumar A; Strieter RM; Burdick MD; Ioannides CG; Efferson CL; El-Naggar AK; Roberts D; Clayman GL; Frederick MJ
Cancer Res; 2004 Nov; 64(22):8262-70. PubMed ID: 15548693
[TBL] [Abstract][Full Text] [Related]
5. Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma.
Ozawa S; Kato Y; Ito S; Komori R; Shiiki N; Tsukinoki K; Ozono S; Maehata Y; Taguchi T; Imagawa-Ishiguro Y; Tsukuda M; Kubota E; Hata R
Cancer Sci; 2009 Nov; 100(11):2202-9. PubMed ID: 19673887
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway.
Gu D; Li H; Wang Z; Chen Q; Jiang J; Zhu H
Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells.
Maehata Y; Ozawa S; Kobayashi K; Kato Y; Yoshino F; Miyamoto C; Izukuri K; Kubota E; Hata R; Lee MC
Free Radic Res; 2010 Aug; 44(8):913-24. PubMed ID: 20815772
[TBL] [Abstract][Full Text] [Related]
8. Modulation of CXCL14 (BRAK) expression in prostate cancer.
Schwarze SR; Luo J; Isaacs WB; Jarrard DF
Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
[TBL] [Abstract][Full Text] [Related]
9. Human p38 delta MAP kinase mediates UV irradiation induced up-regulation of the gene expression of chemokine BRAK/CXCL14.
Ozawa S; Ito S; Kato Y; Kubota E; Hata R
Biochem Biophys Res Commun; 2010 Jun; 396(4):1060-4. PubMed ID: 20478268
[TBL] [Abstract][Full Text] [Related]
10. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected].
Izukuri K; Suzuki K; Yajima N; Ozawa S; Ito S; Kubota E; Hata R
Transgenic Res; 2010 Dec; 19(6):1109-17. PubMed ID: 20333465
[TBL] [Abstract][Full Text] [Related]
11. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
12. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma.
Lung HL; Cheung AK; Xie D; Cheng Y; Kwong FM; Murakami Y; Guan XY; Sham JS; Chua D; Protopopov AI; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Cancer Res; 2006 Oct; 66(19):9385-92. PubMed ID: 17018592
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
[TBL] [Abstract][Full Text] [Related]
14. Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo.
Ito S; Ozawa S; Ikoma T; Yajima N; Kiyono T; Hata R
Biomed Res; 2010 Jun; 31(3):199-206. PubMed ID: 20622470
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent.
Husvik C; Bryne M; Halstensen TS
Eur J Oral Sci; 2009 Oct; 117(5):528-35. PubMed ID: 19758248
[TBL] [Abstract][Full Text] [Related]
16. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy.
Starnes T; Rasila KK; Robertson MJ; Brahmi Z; Dahl R; Christopherson K; Hromas R
Exp Hematol; 2006 Aug; 34(8):1101-5. PubMed ID: 16863917
[TBL] [Abstract][Full Text] [Related]
17. Fasudil suppresses fibrosarcoma growth by stimulating secretion of the chemokine CXCL14/BRAK.
Miyamoto C; Maehata Y; Ozawa S; Ikoma T; Kubota E; Izukuri K; Kato Y; Hata R; Lee MC
J Pharmacol Sci; 2012; 120(3):241-9. PubMed ID: 23099322
[TBL] [Abstract][Full Text] [Related]
18. Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression.
Yeudall WA; Miyazaki H; Ensley JF; Cardinali M; Gutkind JS; Patel V
Oral Oncol; 2005 Aug; 41(7):698-708. PubMed ID: 15935723
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
[TBL] [Abstract][Full Text] [Related]
20. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
